{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6"}]}]}],"denoms":[{"counts":[{"groupId":"OG000","value":"16"}],"units":"Participants"}],"description":"Number of study participants removed from study treatment due to toxicities","groups":[{"description":"Melphalan Lenalidomide Dexamethasone\n\ndexamethasone: 40 mg once weekly\n\nlenalidomide: 10 mg/day days 1-21\n\nmelphalan: 5 mg/m2 days 1-4","id":"OG000","title":"Melphalan Revlimid and Dexamethasone"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"All patients who have had at least one dose of drug.","reportingStatus":"POSTED","timeFrame":"One year","title":"Number of Participants Removed From Study Due to Toxicities","type":"SECONDARY","unitOfMeasure":"Participants"}